DaVita Inc. reported financial results for the quarter ended June 30, 2026, with consolidated revenues of $3.554 billion and diluted earnings per share of $4.02. Operating income reached $579 million, while operating cash flow was $490 million and free cash flow stood at $256 million. The company incurred a new Term Loan B-2 tranche totaling $500 million to repay its revolving line of credit and added remaining proceeds to the balance sheet. Additionally, DaVita repurchased 2.2 million shares for $348 million at an average price of $154.95 per share. The company operates in the healthcare industry, providing outpatient dialysis services and integrated kidney care.
